EMCURE PHARMACEUTICALS
Back to Balance Sheet
|
EMCURE PHARMACEUTICALS Last 5 Year Capital Work in Progress History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Capital Work in Progress | ₹124 Cr | ₹132 Cr | ₹404 Cr | ₹310 Cr | ₹222 Cr |
What is the latest Capital Work in Progress ratio of EMCURE PHARMACEUTICALS ?
| Year | Capital Work in Progress |
|---|---|
| Mar2025 | ₹124 Cr |
| Mar2024 | ₹132 Cr |
| Mar2023 | ₹404 Cr |
| Mar2022 | ₹310 Cr |
| Mar2021 | ₹222 Cr |
How is Capital Work in Progress of EMCURE PHARMACEUTICALS Trending?
| Years | Capital Work in Progress | % Change | |
|---|---|---|---|
| Mar2025 | ₹124 Cr | -6.26 | |
| Mar2024 | ₹132 Cr | -67.20 | |
| Mar2023 | ₹404 Cr | 30.25 | |
| Mar2022 | ₹310 Cr | 39.81 | |
| Mar2021 | ₹222 Cr | - | |
Compare Capital Work in Progress of peers of EMCURE PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| EMCURE PHARMACEUTICALS | ₹32,898.7 Cr | 0.9% | 4.5% | 26.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹433,620.0 Cr | 1% | -0.9% | 6.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹176,087.0 Cr | 1.8% | -2.3% | 1.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹154,837.0 Cr | 3.7% | 6.5% | 44.9% | Stock Analytics | |
| CIPLA | ₹112,194.0 Cr | 0% | 4.7% | -8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,328.0 Cr | -0.2% | 0.7% | -3.4% | Stock Analytics | |
EMCURE PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| EMCURE PHARMACEUTICALS | 0.9% |
4.5% |
26.6% |
| SENSEX | 1.7% |
1.3% |
-7.3% |
You may also like the below Video Courses